Oxford Biomedica plc announced that Dr. Frank Mathias will officially join the company as Chief Executive Officer (CEO) on 27th March 2023. His appointment was previously announced on 22nd November 2022. Dr. Frank Mathias joins the company from Rentschler Biopharma SE, where he has been CEO since 2016.

He successfully transformed Rentschler into a leading global, full-service CDMO and transformed the financials of the business including a three-fold increase in revenue, while also improving efficiencies and profitability at an even faster rate.